10th Annual Cell and Gene Therapy Symposium
Centre for Stem Cell Research (a unit of inStem, Bengaluru), Christian Medical College Campus, Vellore
Time shown in IST (Indian Standard Time)
1:00 to 1:05 PM Prayer by Chaplain
1:05 to 1:15 PM Welcome and introductory remarks: Director, CMC / Principal, CMC / Director, inStem/ Head, CSCR
1:15 to 1:25 PM Remarks by Secretary, Department of Biotechnology, Ministry of Science and Technology, Govt. of India
KEY NOTE ADDRESS
Gene therapy and gene editing for genetic diseases and cancer: a personal journey
Thierry Vanden DriesscheFree University of Brussels &University of Leuven, Belgium
2.30 to 3:00 PM
iPSC based disease modelling of bone marrow failure diseases
RV ShajiCentre for Stem Cell Research, India
Rachel SteegFraunhofer UK Research Limited, Scotland, UK
Poster presentation/ Industry Symposium
Martin H. SteinbergBoston University and Boston Medical Centre, Boston
5:30 to 6:00 PM
Turning Genes into Medicines: Lessons Learned in the Pursuit of Gene Therapy for Haemophilia
Katherine A. HighAsklepios BioPharmaceutical, Inc (AskBio), North Carolina, USA
6:00 to 6:30 PM
Preferential expansion of hematopoietic stem cells enhances gene-modified cell frequency for gene therapy
Saravanabhavan Thangavel Centre for Stem Cell Research, Vellore, India
Session-3: GENE THERAPY
Development of capsid- and genome-modified AAVrh74 vectors for gene therapy of muscular dystrophies
Arun Srivastava University of Florida College of Medicine, USA
Validation of BCL11A as a Therapeutic Target in Sickle Cell Disease: Results from a First-in-Human Clinical Trial
David Williams Harvard Stem Cell InstituteBauer Building, Cambridge, USA
Alok Srivastava Centre for Stem Cell Research, Vellore, India
End of Day-1
Timothy O’brien National University of Ireland, Galway, Ireland
Manufacturing the vector and CAR-T cells in India – The nuts and bolts
Rahul Purwar Indian Institute of Technology Bombay, Mumbai, India
Engineering Genetically Enhanced T cells for clinical applications
Bruce Levine Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
Break
Session-5: CELL AND GENE THERAPY FOR OCULAR DISORDERS
Graziella Pellegrini University of Modena and Reggio Emilia, Modena, Italy
Arkasubhra Ghosh Narayana Netralaya, Bengaluru, India
Advances in iPSC-derived outer retina tissue mimetic: Implications for translational approaches towards cell and gene-based therapy
Ruchira Singh University of Rochester, NewYork, USA
Session-6: IMMUNE CELL THERAPY
Rizwan RomeeHarvard Medical School, Dana Farber Cancer Institute, Boston, USA
Developing genetically-engineered, clinically-scalable, γδ T Cells for the treatment of solid tumours and hematopoietic cancers of children
Trent Spencer Emory University, School of Medicine, USA
Yair Reisner MD Anderson Cancer Centre, Houston, TX, USA
End of Day-2
Session-7: CELL AND GENE THERAPY- INDUSTRY UPDATES
Identification of novel HPFH-like mutations by CRISPR base editing that elevates the expression of fetal hemoglobin
Mohankumar Murugesan Centre for Stem Cell Research, Vellore, India
Genome editing of hematopoietic stem cells
Pietro Genovese Harvard Medical School, Boston, USA
Jonathan Yen St. Jude Children’s Research Hospital, Memphis, USA
Session-9: NON-VIRAL NUCLEIC ACID TRANSFER
Avinash Bajaj Regional Center for Biotechnology, New Delhi
7:30 to 8:00 PM
Development of Liver targeting lipid enabled nucleic acid delivery systems for therapeutic applications
Srujan Marepally Centre for Stem Cell Research, India
8:00 to 8:30 PM
Self-transcribing and replicating RNA based vaccine for SARS-CoV-2
Priya Prakash Karmali Arcturus Therapeutics, San Diego, USA
End of Day-3
CGTS 2021 E-POSTER Part-1 – Click to view / download
CGTS 2021 E-POSTER Part-2 – Click to view / download
CGTS 2021 ABSTRACT BOOK – Click to view / download